| Issue |
Section |
Title |
File |
| Vol 10, No 1 (2014) |
REVIEW |
INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 10, No 1 (2014) |
CLINICAL CASE |
THE ATYPICAL SITE OF URETERAL METASTASIS IN A PATIENT WITH CASTRATION-REFRACTORY PROSTATE CANCER. A CLINICAL CASE AND A REVIEW OF LITERATURE |
(Rus)
|
| Vol 7, No 1 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
USE OF TARGET DRUGS IN A HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER |
(Rus)
|
| Vol 10, No 2 (2014) |
PROSTATE CANCER |
SURGICAL TREATMENT OF PATIENTS WITH PROSTATE CANCER AT HIGH RISK OF PROGRESSION |
(Rus)
|
| Vol 7, No 1 (2011) |
PROSTATE CANCER |
TECHNICAL CHARACTERISTICS OF RADICAL PROSTATECTOMY FOR EARLY CONTINENCE RECOVERY |
(Rus)
|
| Vol 8, No 1 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
ACTIVE OBSERVATION TACTICS IN PATIENTS WITH KIDNEY NEOPLASMS |
(Rus)
|
| Vol 8, No 1 (2012) |
PROSTATE CANCER |
THE RATE AND SITE OF LYMPH NODE METASTASES DURING RADICAL PROSTATECTOMY AND EXTENDED LYMPHADENECTOMY IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 9, No 2 (2013) |
CLINICAL CASE |
DIAGNOSIS AND TREATMENT OF METACHRONOUS TESTICULAR CANCER: A CLINICAL CASE |
(Rus)
|
| Vol 7, No 1 (2011) |
PROSTATE CANCER |
EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 7, No 1 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
POSSIBILITIES OF URINARY TRACT RECONSTRUCTION AFTER TOTAL SMALL PELVIC EXENTERATIONS IN PATIENTS WITH LOCALLY ADVANCED PRIMARY AND RECURRENT RECTAL TUMORS |
(Rus)
|
| Vol 9, No 4 (2013) |
REVIEW |
PERI-OPERATIVE CHEMOTHERAPY IN MUSCLE INVASIVE BLADDER CANCER: OVERVIEW AND A RATIONALE FOR THE NEED TO SEEK ALTERNATIVE TREATMENT: MAGNOLIA CLINICAL TRIAL |
(Rus)
|
| Vol 7, No 2 (2011) |
PROSTATE CANCER |
A ROLE OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER |
(Rus)
|
| Vol 8, No 1 (2012) |
CLINICAL CASE |
RESECTION OF THE S-SHAPED CROSSED DYSTOPIC KIDNEY IN A PATIENT WITH RENAL CELL CARCINOMA |
(Rus)
|
| Vol 9, No 1 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
PROGNOSTIC FACTORS OF SURVIVAL IN NON-MUSCLE-INVASIVE BLADDER CANCER |
(Rus)
|
| Vol 9, No 1 (2013) |
REVIEW |
THE POSSIBILITIES AND MECHANISMS OF ACTION OF HORMONE THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER |
(Rus)
|
| Vol 7, No 3 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
EFFICIENCY OF USING A COMBINATION OF AVASTIN AND LOW-DOSE INTERFERON-Α2A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA |
(Rus)
|
| Vol 7, No 3 (2011) |
PROSTATE CANCER |
RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER |
(Rus)
|
| Vol 8, No 3 (2012) |
LECTURE |
MAINTENANCE INTRAVESICULAR THERAPY WITH BCG VACCINE AS A STANDARD FOR THE PREVENTION AND TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER IN MODERATE AND HIGH RISK GROUPS |
(Rus)
|
| Vol 8, No 2 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
LAPAROSCOPIC NEPHRECTOMY USING RADIOFREQUENCY THERMAL ABLATION |
(Rus)
|
| Vol 8, No 3 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
SOME SPECIFIC FEATURES OF THE DIAGNOSIS AND TREATMENT OF KIDNEY CANCER IN RUSSIA: PRELIMINARY RESULTS OF A MULTICENTER COOPERATIVE STUDY |
(Rus)
|
| Vol 8, No 3 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
EFFICIENCY OF TARGETED THERAPY USED IN THE HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER |
(Rus)
|
| Vol 8, No 4 (2012) |
PROSTATE CANCER |
COMBINATION THERAPY FOR PROSTATE CANCER: CLINICAL OBSERVATIONS |
(Rus)
|
| Vol 10, No 3 (2014) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Metastatic kidney cancer: Choice of first-line therapy |
(Rus)
|
| Vol 10, No 3 (2014) |
REVIEW |
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer |
(Rus)
|
| Vol 10, No 4 (2014) |
LECTURE |
Molecular diagnosis of prostate cancer: Topical issues |
(Rus)
|
| Vol 10, No 4 (2014) |
PROSTATE CANCER |
Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies |
(Rus)
|
| Vol 11, No 2 (2015) |
LECTURE |
Neoadjuvant targeted therapy in patients with renal cell carcinoma |
(Rus)
|
| Vol 11, No 2 (2015) |
PROSTATE CANCER |
Investigation of correlations between different prostate-specific antigen forms and clinical and morphological characteristics of a tumor process in patients with prostate cancer |
(Rus)
|
| Vol 11, No 3 (2015) |
REVIEW |
Chemotherapy in the treatment of metastatic prostate cancer: the present state of the problem |
(Rus)
|
| Vol 12, No 1 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
A system of a unified approach to interpreting prostate magnetic resonance imaging according to the PI-RADSv2 guidelines |
(Rus)
(Eng)
|
| Vol 12, No 1 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Use of sunitinib in patients with metastatic kidney cancer in real clinical practice |
(Rus)
(Eng)
|
| Vol 12, No 2 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficiency and safety of the everolimus in patients with the generalized renal cell carcinoma (multicentral observational study) |
(Rus)
(Eng)
|
| Vol 12, No 2 (2016) |
PROSTATE CANCER |
Methods for the diagnosis and treatment of oligometastases in patients with prostate cancer and progressive disease after radical treatment |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Surgical treatment of the stricture of the lower third of ureter after radiation therapy of pelvic organs |
(Rus)
(Eng)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
APHIG: a new multiparameter index for prostate cancer |
(Rus)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Salvage lymphadenectomy in patients with lymphogenic prostate cancer progression after radical treatment: results of a multicenter study |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Optimization of sequential targeted therapy |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
The efficacy and safety of vinflunine in second-line therapy of patients with disseminated transitional cell carcinoma of the urinary tract in clinical practice |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
PROSTATE CANCER |
Second-line hormonal therapy with the enzalutamid in patients with castrate-resistant prostate cancer |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
CONGRESSES AND CONFERENCES |
Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer |
(Rus)
|
| Vol 13, No 1 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Role of tumor-associated macrophages in renal cell carcinoma pathogenesis |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Germline nonsense-mutations of the SMARCB1 gene in Russian patients with rhabdoid renal tumors |
(Rus)
|
| Vol 12, No 4 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Prospects of 2nd line chemotherapy personalization in patients with metastatic castration-resistant prostate cancer |
(Rus)
|
| Vol 13, No 3 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Multilocular cystic renal neoplasm of low malignant potential: experience of N.N. Lopatkin Scientific Research Institute of Urology and Interventional Radiology |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Application of loop-mediated isothermal amplification of DNA for diagnosis of prostate cancer micrometastases in the lymph nodes |
(Rus)
|
| Vol 13, No 3 (2017) |
CLINICAL CASE |
Neoadjuvant chemohormonal therapy and radical prostatectomy in a patient with lymphogenic metastatic prostate cancer |
(Rus)
|
| Vol 13, No 3 (2017) |
PROSTATE CANCER |
Comparative analysis of the PCA3 gene expression in sediments and exosomes isolated from urine |
(Rus)
|
| Vol 13, No 2 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Targeted therapy in patients with poor-prognosis renal cell carcinoma |
(Rus)
|
| Vol 13, No 3 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Vinflunine as second-line therapy for advanced urothelial carcinoma: Russian observational study |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Prostate cancer brachytherapy. Experience of the branches of the National Medical Research Center of Radiology |
(Rus)
(Eng)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Circulating microRNA expression in connection with prostate cancer lymphogenous metastasis |
(Rus)
|
| Vol 13, No 4 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Expression of platelet-derived growth factor alpha and beta genes PDGFRA and PDGFRB associated with biochemical recurrence of prostate cancer after radical prostatectomy |
(Rus)
(Eng)
|
| Vol 13, No 4 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The problem of early continence recovery after radical prostatectomy |
(Rus)
|
| Vol 13, No 4 (2017) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Current approaches to selection of the 1st line therapy in patients with metastatic hormone-sensitive prostate cancer |
(Rus)
|
| Vol 14, No 2 (2018) |
REVIEW |
Comparison of the EORTC and CUETO prognostic models in non-muscle-invasive bladder cancer |
(Rus)
|
| Vol 14, No 2 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Loop-mediated isothermal amplification: an effective method for express-diagnostics of cancer |
(Rus)
|
| Vol 14, No 1 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Safety of enzalutamide in patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy: a phase II, multicenter, single-arm, open-label study |
(Rus)
|
| Vol 14, No 2 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
NEOADJUVANT AND ADJUVANT CHEMOHORMONAL THERAPY IN PATIENTS WITH HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER: OUR EXPERIENCE |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
NEW TREATMENT STANDARD FOR PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER |
(Rus)
|
| Vol 14, No 4 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Surgical technique stabilization of urethrovesical anastomosis in order to improve the results of early recovery of urine retention after retropubic prostatectomy |
(Rus)
|
| Vol 14, No 4 (2018) |
REVIEW |
The role of molecular genetic alterations in sensitivity of the adjuvant intravesical therapy for non-muscle invasive bladder cancer |
(Rus)
|
| Vol 15, No 1 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Second line chemotherapy in patients with castration-refractory prostate cancer. Ftom clinical studies to practice |
(Rus)
|
| Vol 15, No 2 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The validation results for APhiGT algorithm for clarification of prostate cancer staging before treatment (first step) |
(Rus)
|
| Vol 15, No 3 (2019) |
REVIEW |
KIM-1 as a potential serological/urinological tumor-associated marker of renal cell carcinoma and chemotherapy nephrotoxicity |
(Rus)
|
| Vol 15, No 4 (2019) |
LECTURE |
Basic characteristics and features of the molecular genetic test systems designed for non-invasive diagnostics and prognosis of prostate cancer and bladder cancer |
(Rus)
|
| Vol 15, No 3 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
New possibilities of combined antiandrogen therapy in patients with metastatic hormone-sensitive prostate cancer |
(Rus)
|
| Vol 16, No 1 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The validation of threshold decision ruls and calculator for APhiG algoritm for clarification of prostate cancer staging before treatment |
(Rus)
|
| Vol 15, No 4 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Alpha-therapy using radium-223 chloride in patients with castration-resistant prostate cancer. From clinical researches to routine practice |
(Rus)
|
| Vol 1, No 2 (2005) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
Primary multiple prostate and bladder cancer in patients undergone radical cystoprostatectomy |
(Rus)
|
| Vol 2, No 1 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Review of the paper by D.T. Gouadze, V.T. Chakvetadze, E.V. Daneliya "Cystectomy Sparing the Prostate and Seminal Vesicles" |
(Rus)
|
| Vol 2, No 1 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Do We Treat Prostatic Cancer Correctly? |
(Rus)
|
| Vol 16, No 2 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Immunosuppressive peculiarities of stromal cells of various kidney tumor types |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
KIM-1 (kidney injury molecule 1) in the urine of renal cell carcinoma patients |
(Rus)
|
| Vol 16, No 2 (2020) |
EPIDEMIOLOGY OF UROLOGICAL ONCOLOGICAL DISEASES |
The prevalence of prostate cancer from 2005 to 2010 in terms of patient survival |
(Rus)
|
| Vol 16, No 2 (2020) |
LECTURE |
PI-RADS v2.1: moving towards clarity (comments on the updated version) |
(Rus)
|
| Vol 16, No 1 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Evaluation of the efficacy and safety of cabazitaxel in combination with prednisone in patients with metastatic castration-resistant prostate cancer who have previously received docetaxel chemotherapy in daily clinical practice. Results of a Russian multicenter prospective study |
(Rus)
|
| Vol 16, No 1 (2020) |
LECTURE |
Radium chloride [223Ra] for patients with prostate cancer and skeletal metastases. Clinical recommendations |
(Rus)
|
| Vol 16, No 2 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
New treatment options for advanced urothelial cancer: a combination of atesolizumab with chemotherapy |
(Rus)
|
| Vol 16, No 2 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Comparative clinical and economic analysis of using cabozantinib as second-line therapy for adult patients with advanced renal cell carcinoma |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Surgical treatment of patients with high-risk prostate cancer: long-term outcomes and prognostic factors |
(Rus)
|
| Vol 16, No 4 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
The R.E.N.A.L. nephrometry score in radiologist’s practice |
(Rus)
|
| Vol 16, No 4 (2020) |
REVIEW |
The role of microRNA in the diagnosis of prostate cancer |
(Rus)
|
| Vol 16, No 4 (2020) |
CLINICAL CASE |
Large bladder leiomyoma: a case report |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Combination of nivolumab and ipilimumab in the treatment of disseminated renal cell carcinoma. Realities and prospects |
(Rus)
|
| Vol 16, No 3 (2020) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
An interim analysis of non-interventional study of the epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 16, No 3 (2020) |
REVIEW |
Current opportunities of therapy for patients with non-metastatic castration-resistant prostate cancer |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Comparing the efficacy of laparoscopic and open radical prostatectomy: analysis of treatment outcomes in patients with prostate cancer treated in three federal centers |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
FGFR3, TERT, ТР53 mutations and the FGFR3 gene expression in bladder cancer as prognostic markers |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
An original surgical method for the formation of fascial duplication in the elimination of damage to the anterior rectal wall during prostatectomy |
(Rus)
|
| Vol 16, No 4 (2020) |
REVIEW |
Diferelin® as an effective chemical castration agent for patients with prostate cancer |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Clinical significance of mutations in DNA repair genes in patients with metastatic prostate cancer |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Long-term treatment outcomes of patients with non-clear cell renal cell carcinoma |
(Rus)
|
| Vol 17, No 2 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists |
(Rus)
|
| Vol 17, No 4 (2021) |
TOPICAL PROBLEM |
Bosniak classification version 2019: updated algorithms for the diagnosis of cystic renal masses |
(Rus)
|
| Vol 17, No 4 (2021) |
REVIEWS |
Modern possibilities of application 99mTc-labeled prostate-specific membrane antigen ligands in prostate cancer |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Experience of using 1st line combination immunotherapy in patients with metastatic renal cell carcinoma |
(Rus)
|
| Vol 17, No 4 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Nomograms for predicting the risk of biochemical recurrence in patients with prostate cancer after surgery |
(Rus)
|
| Vol 17, No 3 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Current capabilities in treatment of non-metastatic castration-resistant prostate cancer: effectiveness, safety, and quality of life of patients taking darolutamide |
(Rus)
|
| Vol 18, No 2 (2022) |
TOPICAL PROBLEM |
Medical, social, and economic perspectives of health care development. Prostate Cancer Early Diagnosis and Screening Program |
(Rus)
|
| Vol 17, No 4 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Prostate cancer in disabled settings |
(Rus)
|
| Vol 18, No 2 (2022) |
REVIEWS |
Prerequisites for lithogenesis after radical cystectomy: literature review |
(Rus)
|
| Vol 18, No 3 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Nomograms for predicting local recurrence in prostate cancer patients with a positive resection margin |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Utility of fusion biopsy for choosing prostate cancer patients eligible for focal therapy |
(Rus)
|
| Vol 18, No 3 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Evaluation of quality of life of patients with solitary renal cancer metastases in bones before and after surgical treatment in combination with targeted therapy and without it |
(Rus)
|
| Vol 18, No 3 (2022) |
PROSTATE CANCER |
Prevalence of mutations in DNA repair genes in Russian patients with metastatic castration-resistant prostate cancer |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
An observational multicenter study to evaluate the efficacy and safety of degarelix® for prostate cancer in routine clinical practice |
(Rus)
|
| Vol 18, No 2 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia |
(Rus)
|
| Vol 19, No 2 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
The first experience of using prostate cancer organoids as a model for personalized selection of drugs |
(Rus)
|
| Vol 18, No 3 (2022) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
New lenvatinib and pembrolizumab combination for metastatic renal cell carcinoma in 1st line drug treatment: comparative effectiveness and safety |
(Rus)
|
| Vol 19, No 1 (2023) |
TOPICAL PROBLEM |
Efficacy of avelumab in the treatment of oncourological malignances. Results of registration studies and own experience |
(Rus)
|
| Vol 19, No 1 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of cabozantinib in metastatic renal cell carcinoma patients: Russian multicenter observational study |
(Rus)
|
| Vol 19, No 4 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Multiparametric magnetic resonance imaging in diagnosis of local prostate cancer recurrence after radiation therapy and radical prostatectomy: a unified PI-RR reporting system |
(Rus)
|
| Vol 20, No 2 (2024) |
CLINICAL NOTES |
Late progression of renal cell carcinoma after 32 years: clinical case |
(Rus)
|
| Vol 19, No 3 (2023) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. URINARY BLADDER CANCER |
Impact of using novel antitumor drugs in adult patients with locally advanced or metastatic urothelial carcinoma on reducing cancer mortality in Russia |
(Rus)
(Eng)
|
| Vol 20, No 1 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Optimization of a method for determination of docetaxel sensitivity using prostate cancer organoids |
(Rus)
|
| Vol 20, No 1 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Assessment of miR-21-5p, miR-451a, and miR-144-3p level in urine in differential diagnosis of localized prostate cancer |
(Rus)
|
| Vol 19, No 4 (2023) |
REVIEWS |
Effectiveness and safety of darolutamide as a component of combination therapy in patients with prostate cancer |
(Rus)
|
| Vol 20, No 3 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Comparison of the results of surgical treatment using various types of access in patients with prostate cancer: oncological, functional, and financial effectiveness |
(Rus)
|
| Vol 20, No 2 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Multicenter non-interventional study of prevalence of homologous recombination gene mutations and approaches to treatment of metastatic castration-resistant prostate cancer in Russia (ADAM) |
(Rus)
|
| Vol 20, No 3 (2024) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. PROSTATE CANCER |
Androgen deprivation therapy and cardiological risks in patients with prostate cancer. Are all drugs the same? |
(Rus)
(Eng)
|
| Vol 21, No 2 (2025) |
REVIEWS |
Review of the effectiveness of nuclear magnetic resonance spectroscopy for prostate cancer diagnosis |
(Rus)
|
| Vol 20, No 4 (2024) |
TOPICAL PROBLEM |
Modern approaches to treatment of castration-resistant prostate cancer using targeted radionuclide therapy in patients with bone metastases |
(Rus)
|
